Pharmavite Agrees To $1.9M Settlement In TripleFlex Class Action
This article was originally published in The Rose Sheet
Pharmavite will pay $1.9m and discontinue joint improvement claims for four Nature Made TripleFlex glucosamine products under terms of a class-action settlement in a six-year dispute over the truthfulness of joint renewal and rejuvenation claims.
You may also be interested in...
Food and supplement class action complaints could be slowed by legislation in Congress and by judges potentially de-emphasizing reliance on FDA interpretation of statutes, say lawyers during FDLI conference discussion.
Premier Nutrition is targeted in a class action complaint alleging false health benefit claims for its Joint Juice joint health supplement, including that the product would support and nourish cartilage and lubricate joints.
Steven Cahillane, who left his post as president of Coca-Cola Co.’s Americas division in 2013, is moving to NBTY to replace Jeffrey Nagel after the supplement manufacturer and retailer reported flat sales for its most recent earnings period and after net income dropped nearly 12% during the firm’s previous fiscal year.